首页 › 自身免疫性疾病 › 哥伦比亚特区 › Washington
Washington DC 自身免疫性疾病临床试验
19项针对 自身免疫性疾病的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 距离 7 英里
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Natural History of Bronchiectasis
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
NIAID Centralized Sequencing Protocol
招募中观察性研究欢迎健康志愿者
- Children's National Health System, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Environmental Risk Factors for the Anti-synthetase Syndrome
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
招募中2 期欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
招募中2 期
- National Naval Medical Center, Bethesda · 距离 7 英里
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
- American Oncology Partners of Maryland, PA, Bethesda · 距离 7 英里
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
招募中2/3 期
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda · 距离 7 英里
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
招募中3 期
- Site Number - 1024, Washington D.C.
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 距离 7 英里
- Nih/Nhlbi, Bethesda · 距离 7 英里
Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
X-linked Moesin Associated Immunodeficiency
招募中观察性研究
- National Institutes of Health, Bethesda · 距离 7 英里
其他城市的 自身免疫性疾病试验
- Houston, TX21 项研究
- New York City, NY19 项研究
- Philadelphia, PA16 项研究
- Durham, NC15 项研究
- Boston, MA13 项研究
- Chicago, IL12 项研究
- Los Angeles, CA12 项研究
- Dallas, TX9 项研究
- Cleveland, OH8 项研究
- Atlanta, GA8 项研究
- Milwaukee, WI8 项研究
- Portland, OR8 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 淋巴瘤23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月7日。每项研究自行设定入选标准，由研究团队决定谁能参与。